Serum Institute plans pandemic facility to stockpile vax for the world

Adar Poonawalla, CEO and brain behind the new age SII, says in an interaction with Business Standard that by the end of 2021, the company was making 250 million doses a month

The drive through the sprawling 100-acre campus of Serum Institute of India (SII) at Manjari on the outskirts of Pune is striking as you see pride in the eyes of people who’ve contributed to the making of Covid vaccine some way or the other. The world’s largest vaccine maker, which supplied about 80 per cent of the doses used in India’s Covid vaccination programme, is now working on the next plan.   
 

Serum Institute is building a plug-and-play vaccine making facility for the next pandemic at Manjari. SII wants the new facility to be available to any country that may